Cargando…

C-terminal tail of human immunodeficiency virus gp41: functionally rich and structurally enigmatic

The human immunodeficiency virus (HIV) and acquired immunodeficiency syndrome (AIDS) pandemic is amongst the most important current worldwide public health threats. While much research has been focused on AIDS vaccines that target the surface viral envelope (Env) protein, including gp120 and the gp4...

Descripción completa

Detalles Bibliográficos
Autores principales:	Steckbeck, Jonathan D., Kuhlmann, Anne-Sophie, Montelaro, Ronald C.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Society for General Microbiology 2013
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3542723/ https://www.ncbi.nlm.nih.gov/pubmed/23079381 http://dx.doi.org/10.1099/vir.0.046508-0

Ejemplares similares

Topology of the C-Terminal Tail of HIV-1 gp41: Differential Exposure of the Kennedy Epitope on Cell and Viral Membranes
por: Steckbeck, Jonathan D., et al.
Publicado: (2010)

P12-04. Topology of the C-terminal tail of HIV-1 gp41: Differential exposure of the Kennedy epitope on cell and viral membranes
por: Steckbeck, JD, et al.
Publicado: (2009)

Structural and Functional Comparisons of Retroviral Envelope Protein C-Terminal Domains: Still Much to Learn
por: Steckbeck, Jonathan D., et al.
Publicado: (2014)

The C-terminal tail of HIV-1 envelope: a unique role for conserved LLP arginines in Env functional properties
por: Kuhlmann, A, et al.
Publicado: (2012)

Detailed Topology Mapping Reveals Substantial Exposure of the “Cytoplasmic” C-Terminal Tail (CTT) Sequences in HIV-1 Env Proteins at the Cell Surface
por: Steckbeck, Jonathan D., et al.
Publicado: (2013)

Rate and affinity binding constants determined by SPR spectroscopy reveal differential antigenicity of HIV gp120 and gp140
por: Gearhart, TL, et al.
Publicado: (2012)

Antigenicity of soluble HIV gp140 trimers reveals differences in solution conformation for differing HIV strains
por: Gearhart, TL, et al.
Publicado: (2012)

Six-helix bundle completion in the distal C-terminal heptad repeat region of gp41 is required for efficient human immunodeficiency virus type 1 infection
por: Liu, Dehua, et al.
Publicado: (2018)

Systematic Analysis of Intracellular Trafficking Motifs Located within the Cytoplasmic Domain of Simian Immunodeficiency Virus Glycoprotein gp41
por: Postler, Thomas S., et al.
Publicado: (2014)

The C-terminal tail of the gp41 transmembrane envelope glycoprotein of HIV-1 clades A, B, C, and D may exist in two conformations: an analysis of sequence, structure, and function
por: Hollier, Mark J., et al.
Publicado: (2005)

Meeting Review: 2018 International Workshop on Structure and Function of the Lentiviral gp41 Cytoplasmic Tail
por: Fernandez, Melissa V., et al.
Publicado: (2018)

IgA Targeting Human Immunodeficiency Virus-1 Envelope gp41 Triggers Antibody-Dependent Cellular Cytotoxicity Cross-Clade and Cooperates with gp41-Specific IgG to Increase Cell Lysis
por: Duchemin, Maxence, et al.
Publicado: (2018)

Maternal Envelope gp41 Ectodomain-Specific Antibodies Are Associated With Increased Mother-to-Child Transmission of Human Immunodeficiency Virus-1
por: Naiman, Nicole E, et al.
Publicado: (2020)

Increased infectivity in human cells and resistance to antibody-mediated neutralization by truncation of the SIV gp41 cytoplasmic tail
por: Kuwata, Takeo, et al.
Publicado: (2013)

Regulation of T7 gp2.5 binding dynamics by its C-terminal tail, template conformation and sequence
por: Xu, Longfu, et al.
Publicado: (2023)

Human immunodeficiency virus type 1 activates the classical pathway of complement by direct C1 binding through specific sites in the transmembrane glycoprotein gp41
Publicado: (1991)

gp41: HIV's shy protein
por: Zwick, Michael B, et al.
Publicado: (2004)

Neutralizing Antibodies Against a Specific Human Immunodeficiency Virus gp41 Epitope are Associated With Long-term Non-progressor Status
por: Lucar, Olivier, et al.
Publicado: (2017)

Identification of Anti-gp41 Monoclonal Antibodies That Effectively Target Cytotoxic Immunoconjugates to Cells Infected with Human Immunodeficiency Virus, Type 1
por: Klug, Grant, et al.
Publicado: (2023)

HIV gp41-Mediated Membrane Fusion Occurs at Edges of Cholesterol-Rich Lipid Domains
por: Yang, Sung-Tae, et al.
Publicado: (2015)

Dilation of the Human Immunodeficiency Virus–1 Envelope Glycoprotein Fusion Pore Revealed by the Inhibitory Action of a Synthetic Peptide from gp41
por: Muñoz-Barroso, Isabel, et al.
Publicado: (1998)

Effects of the I559P gp41 Change on the Conformation and Function of the Human Immunodeficiency Virus (HIV-1) Membrane Envelope Glycoprotein Trimer
por: Alsahafi, Nirmin, et al.
Publicado: (2015)

Evaluation of Hematological, Biochemical Profiles and Molecular Detection of Envelope Gene (gp-41) in Human Immunodeficiency Virus (HIV) among Newly Diagnosed Patients
por: Anjum, Asfa, et al.
Publicado: (2022)

An Accurate Confirmation of Human Immunodeficiency Virus Type 1 (HIV-1) and 2 (HIV-2) Infections with a Dot blot assay Using Recombinant p24, gp41, gp120 and gp36 Antigens
por: Ravanshad, Mehrdad, et al.
Publicado: (2004)

Conversion of an immunogenic human immunodeficiency virus (HIV) envelope synthetic peptide to a tolerogen in chimpanzees by the fusogenic domain of HIV gp41 envelope protein
Publicado: (1993)

Correction: Effects of the I559P gp41 Change on the Conformation and Function of the Human Immunodeficiency Virus (HIV-1) Membrane Envelope Glycoprotein Trimer
Publicado: (2015)

Characterization of Humoral Immune Responses against Capsid Protein p24 and Transmembrane Glycoprotein gp41 of Human Immunodeficiency Virus Type 1 in China
por: Li, Xiufen, et al.
Publicado: (2016)

The SARS CoV-2 spike directed non-neutralizing polyclonal antibodies cross-react with Human immunodeficiency virus (HIV-1) gp41
por: Perween, Reshma, et al.
Publicado: (2021)

Rational improvement of gp41-targeting HIV-1 fusion inhibitors: an innovatively designed Ile-Asp-Leu tail with alternative conformations
por: Zhu, Yun, et al.
Publicado: (2016)

The Enigmatic N-Terminal Domain of Proglucagon; A Historical Perspective
por: Conlon, J. Michael
Publicado: (2021)

Neutralizing Antibodies Targeting HIV-1 gp41
por: Caillat, Christophe, et al.
Publicado: (2020)

Characterization of the C-terminal tail of the Arc protein
por: Boldridge, Melissa, et al.
Publicado: (2020)

Identification of human immunodeficiency virus type 1 (HIV-1) gp120-binding sites on scavenger receptor cysteine rich 1 (SRCR1) domain of gp340
por: Chu, Ying, et al.
Publicado: (2013)

Crystal Structure of the Carboxy-Terminal Region of the Bacteriophage T4 Proximal Long Tail Fiber Protein Gp34
por: Granell, Meritxell, et al.
Publicado: (2017)

Development of Protein- and Peptide-Based HIV Entry Inhibitors Targeting gp120 or gp41
por: Pu, Jing, et al.
Publicado: (2019)

Convergent HIV-1 Evolution upon Targeted Destabilization of the gp120-gp41 Interface
por: Torrents de la Peña, Alba, et al.
Publicado: (2021)

Enhancement of human immunodeficiency virus type 1 infection by antisera to peptides from the envelope glycoproteins gp120/gp41 [published erratum appears in J Exp Med 1992 Feb 1;175(2):621]
Publicado: (1991)

Antiviral properties of two trimeric recombinant gp41 proteins
por: Delcroix-Genête, Delphine, et al.
Publicado: (2006)

Conserved positive selection signals in gp41 across multiple subtypes and difference in selection signals detectable in gp41 sequences sampled during acute and chronic HIV-1 subtype C infection
por: Bandawe, Gama P, et al.
Publicado: (2008)

Evolution of the HIV-1 envelope glycoproteins with a disulfide bond between gp120 and gp41
por: Sanders, Rogier W, et al.
Publicado: (2004)

Cannot write session to /tmp/vufind_sessions/sess_r33gg6ahr7jhmqq6ng866cpb51